Janssen, J.

group patient study treatment dasatinib information phase ef ficiency nilotinib learners result group members companion instruction episode member myeloid leukemia problem example format information elements model kirschner leukemia effect myeloid effort element imatinib companion diagnostics context ficiency performance estimate research effectiveness solution neutropenia posttest condition second-line response diagnostic level sweller outcome progression responder –effectivenes participant haematological review memory table solution steps therapy healthcare scenario pharmacogenomic genotype health eye color worked-example science example study anaemia cancer test phase nonresponder psychology interaction dutch strategy ef ficient ficient capacity design testing variance journal